
Global
MEDANTA.NSGlobal Health Limited Price (MEDANTA.NS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
268,607,382
(3.5252)%Income Statement Summary
Revenue | |
Cost of Revenue | |
Gross Profit | |
Operating Expenses | |
Operating Income | |
Other Expenses | |
Net Income |


Income Statement
Global Health LimitedCurrency: INR
YEAR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||
Revenue |
13,677,288,000.00
+0% |
14,411,320,000.00
+5% |
14,824,390,000.00
+3% |
14,306,140,000.00
-3% |
21,559,670,000.00
+51% |
26,942,483,000.00
+25% |
32,751,110,000.00
+22% |
||||||||||||
Cost of Revenue | |||||||||||||||||||
Cost of Revenue | 11,236,773,000.00 | 10,431,610,000.00 | 3,248,280,000.00 | 3,485,580,000.00 | 5,429,260,000.00 | 6,252,849,000.00 | 15,584,050,000.00 | ||||||||||||
Gross Profit | |||||||||||||||||||
Gross Profit |
2,440,515,000.00
+0% |
3,979,710,000.00
+63% |
11,576,110,000.00
+191% |
10,820,560,000.00
-7% |
16,130,410,000.00
+49% |
20,689,634,000.00
+28% |
17,167,060,000.00
-17% |
||||||||||||
Gross Profit Ratio | (0.18%) | (0.28%) | (0.78%) | (0.76%) | (0.75%) | (0.77%) | (0.52%) | ||||||||||||
Operating Expenses | |||||||||||||||||||
Research and Development | 20,700,000.00 | 300,000.00 | 120,000.00 | 270,000.00 | 590,000.00 | 340,000.00 | 420,000.00 | ||||||||||||
General and Administrative | 722,332,000.00 | 3,237,447,000.00 | 333,100,000.00 | 270,700,000.00 | 466,060,000.00 | 3,330,113,000.00 | 5,018,660,000.00 | ||||||||||||
Selling, General & Admin... | 761,965,000.00 | 3,284,090,000.00 | 373,620,000.00 | 294,580,000.00 | 497,240,000.00 | 3,330,113,000.00 | 5,310,510,000.00 | ||||||||||||
Selling & Marketing Exp... | 39,633,000.00 | 46,643,000.00 | 40,520,000.00 | 23,880,000.00 | 31,180,000.00 | 249,068,000.00 | 291,850,000.00 | ||||||||||||
Depreciation and Amortiz... | 863,593,000.00 | 1,016,000,000.00 | 1,150,400,000.00 | 1,232,140,000.00 | 1,297,129,000.00 | 1,499,148,000.00 | 1,727,280,000.00 | ||||||||||||
Other Expenses | 0.00 | 29,010,000.00 | 163,940,000.00 | 79,960,000.00 | 122,440,000.00 | 649,148,000.00 | 0.00 | ||||||||||||
Total Operating Expenses | 1,912,033,000.00 | 3,255,380,000.00 | 10,606,570,000.00 | 9,893,590,000.00 | 12,730,550,000.00 | 15,990,499,000.00 | 5,457,000,000.00 | ||||||||||||
Cost and Exponses | 13,148,806,000.00 | 13,686,990,000.00 | 13,854,850,000.00 | 13,379,170,000.00 | 18,159,810,000.00 | 22,243,348,000.00 | 21,041,050,000.00 | ||||||||||||
Operating Income | |||||||||||||||||||
Operating Income |
594,939,000.00
+0% |
724,330,000.00
+22% |
1,260,430,000.00
+74% |
926,970,000.00
-26% |
3,399,860,000.00
+267% |
5,348,283,000.00
+57% |
11,710,060,000.00
+119% |
||||||||||||
Operating Income Ratio | (0.04%) | (0.05%) | (0.09%) | (0.06%) | (0.16%) | (0.20%) | (0.36%) | ||||||||||||
Other Income and Exp... | |||||||||||||||||||
Interest Income | 67,687,000.00 | 185,900,000.00 | 196,450,000.00 | 177,580,000.00 | 167,220,000.00 | 346,171,000.00 | 498,100,000.00 | ||||||||||||
Interest Expenses | 0.00 | 716,050,000.00 | 509,850,000.00 | 671,010,000.00 | 789,550,000.00 | 779,193,000.00 | 725,390,000.00 | ||||||||||||
Total Other Income/Exp... | -1,061,681,000.00 | 108,350,000.00 | -330,870,000.00 | -309,170,000.00 | -501,889,000.00 | -4,972,320,000.00 | -5,439,070,000.00 | ||||||||||||
EBITDA | |||||||||||||||||||
EBITDA | 1,458,532,000.00 | 2,225,100,000.00 | 2,354,860,000.00 | 2,283,190,000.00 | 4,793,259,000.00 | 6,780,940,000.00 | 8,718,160,000.00 | ||||||||||||
EBITDA ratio | (0.11%) | (0.12%) | (0.16%) | (0.16%) | (0.23%) | (0.25%) | (0.27%) | ||||||||||||
Income Before Tax | |||||||||||||||||||
Income Before Tax | 596,169,000.00 | 832,680,000.00 | 638,670,000.00 | 324,640,000.00 | 2,805,610,000.00 | 4,492,903,000.00 | 6,270,990,000.00 | ||||||||||||
Income Before Tax Ratio | (0.04%) | (0.06%) | (0.04%) | (0.02%) | (0.13%) | (0.17%) | (0.19%) | ||||||||||||
Income Tax Expense | |||||||||||||||||||
Income Tax Expense | 267,456,000.00 | 319,390,000.00 | 275,400,000.00 | 36,590,000.00 | 843,590,000.00 | 1,232,110,000.00 | 1,490,390,000.00 | ||||||||||||
Net Income | |||||||||||||||||||
Net Income | 328,713,000.00
+0% |
513,030,000.00
+56% |
363,270,000.00
-29% |
288,050,000.00
-21% |
1,961,979,000.00
+581% |
3,260,790,000.00
+66% |
4,781,940,000.00
+47% |
||||||||||||
Net Income Ratio | (0.02%) | (0.04%) | (0.02%) | (0.02%) | (0.09%) | (0.12%) | (0.15%) | ||||||||||||
Earning Per Share | |||||||||||||||||||
Basic EPS | 1.30 | 2.06 | 1.45 | 1.15 | 7.78 | 12.58 | 17.80 | ||||||||||||
Diluted EPS | 1.30 | 2.04 | 1.44 | 1.14 | 7.77 | 12.57 | 17.80 | ||||||||||||
Share Outstanding | |||||||||||||||||||
Basic Share Outstanding | 252,080,714.00 | 248,985,547.00 | 250,255,111.00 | 251,408,994.00 | 252,163,050.00 | 259,208,847.00 | 268,607,382.00 | ||||||||||||
Diluted Share Outstanding | 252,108,870.00 | 251,528,633.00 | 251,559,894.00 | 252,056,385.00 | 252,379,252.00 | 259,460,832.00 | 268,607,382.00 |